by Perfectus Biomed | News
New Standard Notification – ISO 4768:2023 the measurement of anti-biofilm activity on plastic and other non-porous surfaces was released this month.
This marks a key progressive step in anti-biofilm testing standards. The method is to support material development and...
by Perfectus Biomed | News
New and novel products are a necessity in the medical device market. Industry investment in innovation delivers life enhancing healthcare devices, diagnostics, and digital solutions. Hand-in-hand with product innovation is its innovative test methods, to support efficacy...
by Perfectus Biomed | News
We are once again supporting the NBIC Biofilm Week 2022 campaign, highlighting research to prevent, detect, manage, and engineer biofilms.
Perfectus Biomed Group, now part of NAMSA, are thrilled to take this opportunity to launch our Biofilm Spotlight Interview Series....
by Perfectus Biomed | News
In order to ensure medical devices are safe for use, regulatory bodies require manufacturers to demonstrate adequate inactivation and removal of viruses. Perfectus Biomed, now part of NAMSA, can help you with this key validation step.
A crucial element in the product...
by Perfectus Biomed | News
NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group, a UK founded laboratory, providing customized microbiological services.
“Perfectus Biomed Group...
Thank you to National Biofilm Innovation Centre (NBIC) for another really impressive showcase event on 12 September 2023. We were lucky enough to be there in 2017 at the NBIC launch event and we have been continually impressed and supportive of their endeavours to...